Funded Tech Companies
Synchron
Wondering who provided funding to Synchron? T.rx Capital, Protocol Lab and Double Point Ventures joined the equity holders in this innovative medical devices company.
Company Overview
Company Name
Synchron
Company Status
Private & Independent
Industry
Funding Rounds
Total Funding
Contact Information
Mailing Address
1999 S. Bascom Ave. 700
Campbell, CA 95008
USA
Campbell, CA 95008
USA
Phone
Undisclosed
Website
Email Address
Not Recorded
Company Background Information
Overview
Synchron, a US based neural interface company, is developing the STENTRODE, the world's first endovascular electrode array. The STENTRODE is a minimally invasive implantable device designed to interpret signals from the brain.
Profile
Social Media
Company News
Facebook
YouTube
Last Transaction
11/6/2025
Financing History
Date
Type
Amount
Management Team
Title
Name
Email & Social
Chairman
Martin Dieck
Chief Executive Officer
Thomas Oxley
Chief Technical Officer
Nicholas Opie
VP - Bus. Development
Rahul Sharma
Company Investors
- T.rx Capital
- Protocol Lab
- Double Point Ventures (Campbell Murray)
- Khosla Ventures
- Arch Venture Partners
- METIS Innovative
- K5 Global
- Qatar Investment Authority
- In-Q-Tel
- Bezos Expeditions
- Shanda Group
- Moore Strategic Ventures
- Forepont Capital Partners
- University of Melbourne
- Neurotechnology Investors
- Gates Frontier Fund
- Reliance Industries
- ID8 Investments
- Greenoaks Global
- Alumni Ventures
- DARPA
Browse more funded tech companies:
Share this article
About Our VC Transaction Database
Our data comes from VentureDeal.com, a leading supplier of venture capital funding data.
Additional Resources for Entrepreneurs